                         SEQUENCE LISTING

<110>  UMC Utrecht Holding B.V.
 
<120>  Method for preventing myocardial infarction-related complications

<130>  P30707PC00

<150>  US61/406,591
<151>  2010-10-26

<160>  16    

<170>  PatentIn version 3.5

<210>  1
<211>  28
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Consensus amino acid sequence corresponding to amino acids 36-60 
       of the EDA domain of fibronectin-EDA


<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  Xaa can be Asp or Glu

<220>
<221>  misc_feature
<222>  (9)..(9)
<223>  Xaa can be Ile or Val

<220>
<221>  misc_feature
<222>  (10)..(10)
<223>  Xaa can be His or Arg or Lys

<220>
<221>  misc_feature
<222>  (13)..(13)
<223>  Xaa can be Phe or Leu or Ser

<220>
<221>  misc_feature
<222>  (17)..(17)
<223>  Xaa can be Asp or Glu

<220>
<221>  misc_feature
<222>  (19)..(22)
<223>  Xaa can be Asp or Glu

<220>
<221>  misc_feature
<222>  (27)..(27)
<223>  Xaa can be Asn or His

<400>  1

Thr Tyr Ser Ser Pro Glu Xaa Gly Xaa Xaa Glu Leu Xaa Pro Ala Pro 
1               5                   10                  15      


Xaa Gly Xaa Xaa Xaa Xaa Thr Ala Glu Leu Xaa Gly 
            20                  25              


<210>  2
<211>  27
<212>  PRT
<213>  Homo sapiens

<400>  2

Thr Tyr Ser Ser Pro Glu Asp Gly Ile His Glu Leu Phe Pro Ala Pro 
1               5                   10                  15      


Asp Gly Glu Glu Asp Thr Ala Glu Leu Gln Gly 
            20                  25          


<210>  3
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  primer collagen-1 forward

<400>  3
tcaaggtcta ctgcaacatg g                                                 21


<210>  4
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  primer collagen-1 reverse

<400>  4
aatccatcgg tcatgctctc t                                                 21


<210>  5
<211>  23
<212>  DNA
<213>  Artificial sequence

<220>
<223>  primer collagen-3 forward

<400>  5
cgtaagcact ggtggacaga ttc                                               23


<210>  6
<211>  22
<212>  DNA
<213>  Artificial sequence

<220>
<223>  primer collagen-3 reverse

<400>  6
gcacatcaac gacatcttca gg                                                22


<210>  7
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  primer fibronectin-EDA forward

<400>  7
acgtggttag tgtttatgct c                                                 21


<210>  8
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  primer fibronectin-EDA reverse

<400>  8
tggaatcgac atccacatca g                                                 21


<210>  9
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  primer p0 forward

<400>  9
ggacccgaga agacctcctt                                                   20


<210>  10
<211>  24
<212>  DNA
<213>  Artificial sequence

<220>
<223>  primer p0 reverse

<400>  10
gcacatcact cagaatttca atgg                                              24


<210>  11
<211>  21
<212>  DNA
<213>  Artificial sequence

<220>
<223>  primer lysyl-oxidase forward

<400>  11
cgcaaagagt gaagaaccaa g                                                 21


<210>  12
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  primer lysyl-oxidase reverse

<400>  12
ggcatcaagc aggtcatag                                                    19


<210>  13
<211>  22
<212>  DNA
<213>  Artificial sequence

<220>
<223>  primer MCP-1 forward

<400>  13
gatcggaacc aaatgagatc ag                                                22


<210>  14
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  primer MCP-1 reverse

<400>  14
gtggaaaagg tagtggatgc                                                   20


<210>  15
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  primer TIMP-2 forward

<400>  15
cacccgcaac aggcgtttt                                                    19


<210>  16
<211>  20
<212>  DNA
<213>  Artificial sequence

<220>
<223>  primer TIMP-2 reverse

<400>  16
tttcctccaa cgtccagcga                                                   20


